AC
GILD icon

AXQ Capital’s Gilead Sciences GILD Stock Holding History

AXQ Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Buy
+27,106
New +$3.57M 0.37% 52
2025
Q4 		– Sell
-13,757
Closed -$1.53M – 810
2025
Q3 		$1.53M Buy
+13,757
New +$1.56M 0.59% 13
2024
Q3 		– Sell
-21,659
Closed -$1.49M – 494
2024
Q2 		$1.49M Sell
21,659
-2,841
-12% -$190K 0.35% 97
2024
Q1 		$1.79M Buy
+24,500
New +$1.88M 0.43% 33
2023
Q1 		– Sell
-12,553
Closed -$1.08M – 538
2022
Q4 		$1.08M Buy
+12,553
New +$994K 0.75% 24

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AXQ Capital's GILD Position: Q2 2026 in Review

AXQ Capital opened a new position in Gilead Sciences (GILD) in Q2 2026: 27,106 shares worth $3.42M. The stake represents 0.37% of the portfolio and ranks #52 among its holdings. This is a return to the name: AXQ Capital previously reported a position in GILD as recently as Q3 2025.

AXQ Capital first reported a position in GILD in Q4 2022 and has held it in 5 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • AXQ Capital held 27,106 shares of Gilead Sciences worth $3.42M as of Q2 2026.
  • Gilead Sciences was a new AXQ Capital position in Q2 2026.
  • Gilead Sciences made up 0.37% of AXQ Capital's portfolio in Q2 2026, its #52 holding.
  • AXQ Capital first reported a position in Gilead Sciences in Q4 2022 and has held it in 5 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.